Holding(s) in Company

RNS Number : 4787X
Hikma Pharmaceuticals Plc
25 June 2008
 



Form TR-1 with annex. FSA Version 2.1 updated April 2007


For filings with the FSA include the annex

For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares



1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Hikma Pharmaceuticals PLC


2. Reason for notification (yes/no)


An acquisition or disposal of voting rights


Yes 


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify):______________



3. Full name of person(s) subject to notification obligation:

Genesis Asset Managers LLP


4. Full name of shareholder(s) (if different from 3):



5. Date of transaction (and date on which the threshold is crossed or reached if different):

12 June 2008


6. Date on which issuer notified:

23 June 2008


7. Threshold(s) that is/are crossed or reached:

3%





















8: Notified Details

A: Voting rights attached to shares


Class/type of shares

If possible use ISIN code




GB00B0LCW083

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares



 

5,560,993

Number of voting rights


 

5,560,993

Number of shares



 

5,647,800

Number of voting rights

Percentage of voting rights


Direct

 

5,647,800


Indirect

 

N/A


Direct 

 

3


Indirect

 

N/A



B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A








Total (A+B)


Number of voting rights


Percentage of voting rights

5,647,800

3%



















9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:



Proxy Voting:


10. Name of proxy holder:


N/A

11. Number of voting rights proxy holder will cease to hold:


N/A

12. Date on which proxy holder will cease to hold voting rights:


N/A


13. Additional information:



14 Contact name:


Henry Knowles

15. Contact telephone name:


0207 399 2799


For notes on how to complete form TR-1 please see the FSA website.   

Note: Annex should only be submitted to the FSA not the issuer


Annex: Notification of major interests in shares



A: Identity of the persons or legal entity subject to the notification obligation

Full name 

(including legal form of legal entities)



Contact address 

(registered office for legal entities)



Phone number & email



Other useful information 

(at least legal representative for legal persons)




B: Identity of the notifier, if applicable

Full name



Contact address



Phone number & email



Other useful information


(e.g. functional relationship with the person or legal entity subject to the notification obligation)



C: Additional information




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVSWRWARNURR
UK 100

Latest directors dealings